Whereas germline NF2 mutations lead to neurofibromatosis type 2, somatic mutations in the NF2 gene inhibit NF2’s tumor suppressive effects, thereby promoting the formation of various cancerous tumors [13,15]. The gene discussed is NF2; the disease is NF2-related schwannomatosis.